Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011867

Chairman and CEO acquired 454 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2024-06-13 Other acquisition 10b5-1 +25 $1.52 $38 5,695,582 D
KAZIMI A J Chairman and CEO 2024-06-14 Other acquisition 10b5-1 +48 $1.50 $72 5,695,630 D
KAZIMI A J Chairman and CEO 2024-06-17 Other acquisition 10b5-1 +41 $1.49 $61 5,695,671 D
KAZIMI A J Chairman and CEO 2024-06-18 Other acquisition 10b5-1 +41 $1.57 $64 5,695,712 D
KAZIMI A J Chairman and CEO 2024-06-20 Other acquisition 10b5-1 +41 $1.53 $63 5,695,753 D
KAZIMI A J Chairman and CEO 2024-06-21 Other acquisition 10b5-1 +41 $1.49 $61 5,695,794 D
KAZIMI A J Chairman and CEO 2024-06-24 Other acquisition 10b5-1 +44 $1.59 $70 5,695,838 D
KAZIMI A J Chairman and CEO 2024-06-25 Other acquisition 10b5-1 +44 $1.54 $68 5,695,882 D
KAZIMI A J Chairman and CEO 2024-06-26 Other acquisition 10b5-1 +44 $1.50 $66 5,695,926 D
KAZIMI A J Chairman and CEO 2024-06-27 Other acquisition 10b5-1 +44 $1.52 $67 5,695,970 D
KAZIMI A J Chairman and CEO 2024-06-28 Other acquisition 10b5-1 +41 $1.50 $62 5,696,011 D
Loading xslF345X05/marketforms-66482.xml…